CompoAtlas

Prostatic Complex

Prostatic Complex, licence 80066273: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Nutragenius Inc.
NPN or DIN-HM
80066273
Status
Inactive licence
Licence date
7 January 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Solanum lycopersicum

Source : Chair (fruit)

Potency : 10.0 % lycopene

100.0 milligrammeNot calculated
Vaccinium angustifolium

Source : Fruit

Extraction ratio : 40:1

Dry plant equivalent : 400 milligramme

10.0 milligrammeNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : bactéries, levures

30.0 milligrammeNot calculated
3,3',4',5,7-Pentahydroxyflavone

Source : Vaccinium myrtillus - Fruit

120.0 milligrammeNot calculated
Vitamine C

Source : Acide ascorbique

50.0 milligramme100,000 µg
Serenoa repens

Source : Fruit

Potency : 90.0 % fatty acids

100.0 milligrammeNot calculated
Ginkgo biloba L.

Source : Feuille

Extraction ratio : 50:1

Dry plant equivalent : 3 Grammes

Potency : 24.0 % flavone glycosides

60.0 milligrammeNot calculated
Ginkgo biloba L.

Source : Feuille

Potency : 6.0 % terpene lactones

Not specifiedNot calculated

Non-medicinal ingredients

chlorophylle, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified1.0 Capsule2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Source of antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80066273

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line